{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T11:22:52Z","timestamp":1768216972806,"version":"3.49.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"The Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Psychological distress is common in psoriasis, but its prevalence and possible biological correlates in young adults with well-controlled disease remain unclear. In this study, we aimed to assess the presence of anxiety and depressive symptoms in young, well-treated psoriasis patients, who were primarily expected to have no or minimal psychological distress, and to explore potential associations with inflammatory and metabolic markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a cross-sectional cohort of 80 psoriasis patients (women\/male: 45\/35; mean age 38.7 \u00b1 4.2 years) psychological symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS), with HADS-A and HADS-D subscales evaluating anxiety and depression symptoms. Exploratory associations with inflammatory cytokines and metabolic indices were examined using regression analyses and random forest machine-learning models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Anxiety symptoms were identified only in 5 patients (women\/male: 4\/1; 6%), and depressive symptoms in 10 patients (women\/male: 6\/4; 12%). Affected individuals had clinically significant anxiety (HADS-A: 12\/21) and borderline depressive symptoms (HADS-D: 10\/21). No significant associations between HADS scores and inflammatory or metabolic markers were found. Exploratory random forest models tentatively identified IL-6, IL-23, FIB-4, HOMA-IR, and waist circumference as the strongest contributors to variance in depressive symptoms, while no clear contributors emerged for anxiety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Anxiety and depressive symptoms can occur in well-treated young psoriasis patients. Although prevalence is low, their impact may be substantial. These findings indicate the potential importance of targeted psychological screening in this population. Associations with inflammatory and metabolic markers should be considered hypothesis-generating and warrant validation in larger, independent cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1753103","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:12:53Z","timestamp":1768205573000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychological distress in young adults with well-controlled psoriasis"],"prefix":"10.3389","volume":"16","author":[{"given":"Eva Klara","family":"Merzel \u0160abovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadeja","family":"Kraner \u0160umenjak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miodrag","family":"Jani\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad141","article-title":"Electronic screening for mental illness in patients with psoriasis","volume":"189","author":"Bechman","year":"2023","journal-title":"Br J Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00403-025-03808-9","article-title":"Psychological burden and its correlates in patients with chronic plaque psoriasis attending three tertiary care centers in Sri Lanka","volume":"317","author":"Liyanage","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s00403-025-04181-3","article-title":"Psychiatric disorders in psoriatic patients: a cross-sectional study in multi-government hospitals","volume":"317","author":"Abdel -Azim","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.508","article-title":"The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: A systematic review and meta-analysis","volume":"134","author":"Dowlatshahi","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13615","article-title":"A prospective cross-sectional study of anxiety and depression in patients with psoriasis in Singapore","volume":"30","author":"Tee","year":"2016","journal-title":"J Eur Acad Dermatol Venereology."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.15577","article-title":"Prevalence and factors associated with depression and anxiety in patients with psoriasis","volume":"30","author":"Pollo","year":"2021","journal-title":"J Clin Nurs"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12355","article-title":"Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis","volume":"169","author":"Dowlatshahi","year":"2013","journal-title":"Br J Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-023-01060-5","article-title":"Psychosocial burden of psoriasis: A systematic literature review of depression among patients with psoriasis","volume":"13","author":"Luna","year":"2023","journal-title":"Dermatol Ther (Heidelb)."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15012","article-title":"Anxiety and depression in patients with moderate-to-severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the Phase 3 VOYAGE 2 study","volume":"32","author":"Gordon","year":"2018","journal-title":"J Eur Acad Dermatol Venereology."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000498848","article-title":"Comparison of hospital anxiety and depression scale (HADS) and zung self-rating anxiety\/depression scale (SAS\/SDS) in evaluating anxiety and depression in patients with psoriatic arthritis","volume":"236","author":"Yue","year":"2020","journal-title":"Dermatology."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2021.01.014","article-title":"Validity of the Hospital Anxiety and Depression Scale (HADS) in primary care patients in Colombia","volume":"74","author":"Cassiani-Miranda","year":"2022","journal-title":"Gen Hosp Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00403-024-03403-4","article-title":"Residual metabolic burden in young psoriasis patients successfully treated with biologics","volume":"316","author":"Merzel \u0160abovi\u0107","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/00368504241287893","article-title":"Arterial function is preserved in successfully treated patients with psoriasis vulgaris","volume":"107","author":"Merzel \u0160abovi\u0107","year":"2024","journal-title":"Sci Prog"},{"key":"B15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12026-024-09584-4","article-title":"Residual non-specific and disease-specific inflammatory markers in successfully treated young psoriasis patients: a cross-sectional study","volume":"73","author":"Merzel \u0160abovi\u0107","year":"2025","journal-title":"Immunol Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1611827","article-title":"Overall hemostatic potential as a marker of subclinical hypercoagulability in treated psoriasis patients","volume":"12","author":"Merzel \u0160abovi\u0107","year":"2025","journal-title":"Front Med (Lausanne)."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"adv00769","DOI":"10.2340\/actadv.v102.1386","article-title":"Prevalence and odds of anxiety disorders and anxiety symptoms in children and adults with psoriasis: systematic review and meta-analysi","volume":"102","author":"Jalenques","year":"2022","journal-title":"Acta Derm Venereol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.05.009","article-title":"Psoriasis and mental health in adolescents: A cross-sectional study within the Danish National Birth Cohort","volume":"358","author":"Brandi","year":"2024","journal-title":"J Affect Disord"},{"key":"B20","doi-asserted-by":"publisher","first-page":"115078","DOI":"10.1016\/j.psychres.2023.115078","article-title":"Epidemiology of mental health comorbidity in patients with psoriasis: An analysis of trends from 1986 to 2019","volume":"321","author":"Liu","year":"2023","journal-title":"Psychiatry Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1161\/CIRCULATIONAHA.120.052428","article-title":"Improving the effectiveness of psychological interventions for depression and anxiety in cardiac rehabilitation: PATHWAY\u2014A single-blind, parallel, randomized, controlled trial of group metacognitive therapy","volume":"144","author":"Wells","year":"2021","journal-title":"Circulation."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-05244-8","article-title":"Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patients","volume":"28","author":"Annunziata","year":"2020","journal-title":"Supportive Care Cancer."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2005.03.002","article-title":"Using the Hospital Anxiety and Depression Scale to screen for depression in cardiac patients","volume":"27","author":"Bambauer","year":"2005","journal-title":"Gen Hosp Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/jdv.13891","article-title":"The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials","volume":"31","author":"Fleming","year":"2017","journal-title":"J Eur Acad Dermatol Venereology."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.04.012","article-title":"Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician\u2019s global assessment","volume":"51","author":"Langley","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"105915","DOI":"10.1016\/j.psyneuen.2022.105915","article-title":"Trauma, psychological distress and markers of systemic inflammation among US women: A longitudinal study","volume":"145","author":"Lawn","year":"2022","journal-title":"Psychoneuroendocrinology."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.47626\/2237-6089-2022-0599","article-title":"The impact of inflammatory and metabolic markers on depression, anxiety, and cognition after COVID-19: a narrative review","volume":"46","author":"Diniz","year":"2024","journal-title":"Trends Psychiatry Psychother"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2174\/1573397116666201211124815","article-title":"Prevalence of anxiety, depression, sleep disturbance, fibromyalgia, obesity, and gastroesophageal disease in patients with rheumatic diseases","volume":"17","author":"Azarfar","year":"2021","journal-title":"Curr Rheumatol Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00014-5","article-title":"Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"6","author":"Barberio","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1659346","article-title":"The complex interplay between psoriasis and depression: from molecular mechanisms to holistic treatment approaches","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.699848","article-title":"Depression and obesity in patients with psoriasis and psoriatic arthritis: is IL-17-mediated immune dysregulation the connecting link","volume":"12","author":"Zafiriou","year":"2021","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/apha.70019","article-title":"Proinflammatory cytokines and neuropeptides in psoriasis, depression, and anxiety","volume":"241","author":"Keenan","year":"2025","journal-title":". Acta Physiologica"},{"key":"B34","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/ijms24010578","article-title":"Selected biomarkers of depression: what are the effects of cytokines and inflammation","volume":"24","author":"Harsanyi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.714057","article-title":"Depression and anxiety disorders in patients with inflammatory bowel disease","volume":"12","author":"Hu","year":"2021","journal-title":"Front Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.50.6.613","article-title":"An ultra-brief screening scale for anxiety and depression: the PHQ\u20134","volume":"50","author":"Kroenke","year":"2009","journal-title":"Psychosomatics."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1753103\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:12:54Z","timestamp":1768205574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1753103\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":36,"alternative-id":["10.3389\/fpsyt.2025.1753103"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1753103","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1753103"}}